they contained less CD40L and P-selectin. Peak density platelets showed less surface-bound fibrinogen. These platelets contained less CD40L and P-selectin than nearby denser populations. The light platelets had more surface-bound fibrinogen than peak platelets together with elevated concentrations of CD40L. In ET, the malignant platelet production could exist together with platelets originating from normal megakaryocytes. It is also possible that clonal megakaryocytes produce platelets covering the entire density span. The 'normal' density distribution offers a tenable explanation as to why serious bleedings do not occur more frequently.
In health, platelet density differs within the span of 1.04-1.08 kg/l [6] [7] [8] . The variation depends for the most part on platelet organelle content in that high-density platelets have more ␣ and dense granules. They further contain more glycogen [8] . Platelet density is related to size and metabolic activity [6] . Some authors take the view that density decreases as platelets circulate [9, 10] . Other studies suggest that recently created platelets are less dense and that density increases with age [11] [12] [13] . Finally, evidence exists indicating that platelet density does not change in vivo [14] [15] [16] .
The location of CD40 ligand (CD40L) in resting platelets is not known [17] . CD40L is rapidly translocated to the platelet surface upon activation [18] . In resting platelets, P-selectin is located in ␣ granules. The molecule is moved to the cell surface upon activation [19, 20] . Previous work from our laboratory shows that healthy individuals have high-density platelets with more surfacebound fibrinogen in vivo. Consequently, they circulate in a more activated state [21] . We also described that lowdensity populations display more membrane-bound fibrinogen indicating platelet activity. In contrast, the study also demonstrates that peak density platelets were less activated as estimated from in vivo platelet-bound fibrinogen [21] .
The current study evaluates whether the clonal platelet production in ET affects platelet density variations. In particular, it investigates and characterizes platelet density subpopulations with respect to platelet in vivo activity. To further characterize these populations, we determined intracellular concentrations of CD40L and P-selectin.
Subjects and Methods
We included 2 ET patients, and 2 healthy blood donors served as controls. The diagnosis was established according to 2001 WHO diagnostic criteria. Peripheral blood samples (7.5 ml) were collected and anticoagulated with 2.5 ml 0.129 M disodium citrate. The separation procedure has been described in detail [22] . In short, 2 isotonic Percoll TM (GE Healthcare Bio-Sciences AB, Sweden) solutions (1.04 and 1.09 kg/l) were fabricated by mixing appropriate volumes of Percoll, H 2 O and a platelet-inhibitory solution composed of (a) 2.7 mmol/l theophylline dissolved in 0.15 mol Tris-chloride buffer (pH 7.4 at 25 ° C), (b) 1 mg/l prostaglandin E 1 and 1 ml 95% ethanol in H 2 O and (c) 0.15 M Na 2 citrate and 0.13 M Na 3 EDTA (pH 7.4 at 25 ° C). A two-chamber gradient maker was used to manufacture linear Percoll 50-ml gradients covering the density span of 1.04-1.09 kg/l. Subsequently, citrate anticoagulated whole blood was carefully layered on top of the gradient. It was then centrifuged at 2,767 g for 1.5 h [22] . Thereafter, the bottom of the test tube was perforated and the gradient divided into 16 or 17 aliquots (density fractions), each containing approximately 2 ml of the test tube content. In all fractions, platelet counts and platelet fibrinogen binding without antagonist challenge were determined. Furthermore, to ensure the efficacy of the inhibitory solution, platelet-bound fibrinogen was analyzed after ADP challenge (8.5 mol/l). Subsequently, cells were lysed using Triton X-100 (final concentration 1%). After removing cell debris, intracellular concentrations of CD40L and P-selectin were determined in all platelet density fractions. Platelet counting was done electronically. Platelet-bound fibrinogen was determined with a Beckman Coulter EPICS XL-MCL TM Flow Cytometer (Coulter Corp., USA) as previously described [23] . In brief, a fluorescein isothiocyanate-conjugated chicken antihuman fibrinogen polyclonal antibody (Biopool AB, Sweden) was applied to detect surface-bound fibrinogen. Platelets were identified with a phycoerythrin-conjugated antibody against GPIb (Dako AS, Denmark). The number of platelets (%) having more surface-bound fibrinogen than a predetermined control was used as an experimental parameter. Commercial ELISA kits were employed to determine CD40L and P-selectin (R&D, UK).
Results
ET patient No. 1 ( fig. 1 ) showed 1 density peak ( fig. 1 a) . High-density platelets displayed more cell-bound fibrinogen than peak platelets, both spontaneously ( fig. 1 b) and after ADP challenge ( fig. 1 c) . The 2 densest fractions contained platelets with less intracellular CD40L and P-selectin ( fig. 1 d, e) than the neighboring less dense platelets. Peak density platelets circulate in a less activated state than the densest populations as estimated from plateletbound fibrinogen ( fig. 1 b) . The lightest platelets contained more CD40L and P-selectin than the neighboring populations ( fig. 1 d, e) . Finally, figure 1 e shows that the lightest platelets had more intracellular P-selectin than peak platelets.
The second ET patient ( fig. 2 ) confirmed previous results and showed 1 platelet density peak. Again, highdensity platelet populations displayed more plateletbound fibrinogen, both spontaneously and after ADP challenge ( fig. 2 b, c) . In addition, these populations contained less CD40L ( fig. 2 d) and P-selectin ( fig. 2 e) than the adjoining less dense platelets. Compared with the neighboring denser populations, peak density platelets again demonstrated less platelet-bound fibrinogen in conjunction with lower intracellular CD40L and P-selectin. Low-density populations displayed more surfacebound fibrinogen than nearby platelets indicating platelet activity ( fig. 2 b, c) . The amount of intracellular CD40L was higher than the surrounding denser platelets ( fig. 2 d) . Finally, these platelets also contained more intracellular P-selectin ( fig. 2 e) Figure 3 displays results for the first healthy subject. The platelet distribution in the gradient revealed a single peak ( fig. 3 a) . High-density platelets again displayed more spontaneous platelet-bound fibrinogen, and ADP challenge did not affect this finding ( fig. 3 b, c) . Similarly to ET patients, these platelets had lower intracellular levels of CD40L and P-selectin ( fig. 3 d, e) . The densest platelets, however, constitute an exception as they contained more intracellular P-selectin. The subject had peak density platelets with less surface-bound fibrinogen ( fig. 3 b,  c) . These populations further demonstrated lower intracellular CD40L and P-selectin content ( fig. 3 d, e) than the surrounding platelets. Finally, again the lightest platelets had more surface-bound fibrinogen and more intracellular CD40L and P-selectin ( fig. 3 d, e) than peak platelets.
The analysis of platelets from the second healthy participant demonstrated similar results ( fig. 4 ) . Again, 1 density peak was found ( fig. 4 a) . Without agonist challenge, high-density platelets showed enhanced platelet fibrinogen binding ( fig. 4 b) . In agreement with previous subjects, these platelets displayed lower amounts of intracellular CD40L and P-selectin ( fig. 4 d, e) . Peak density platelets again showed less platelet-bound fibrinogen than the densest platelets, both unstimulated ( fig. 4 b) and after ADP challenge ( fig. 4 c) . Once more, these platelet populations displayed low amounts of intracellular CD40L and P-selectin ( fig. 4 d, e) . Finally, the lightest platelets showed more surface-bound fibrinogen ( fig. 4 c) than peak platelets. The lightest platelets also demonstrated more intracellular CD40L and P-selectin ( fig. 4 d, e) than peak density platelets.
Discussion
The current study reveals similarities between platelets of ET patients and those of healthy individuals with respect to platelet density ( fig. 1-4 ) . All participants showed peak density platelets with less surface-bound fibrinogen. Most of these platelets had lower intracellular CD40L and P-selectin levels than nearby denser populations. In addition, high-density platelets were more activated in vivo, i.e. they displayed more membrane-bound fibrinogen than peak platelets. High-density cells contained less intracellular CD40L and P-selectin than neighboring less dense platelets. The finding indicates release reactions occurring in vivo. Finally, the study confirms previous work [21] in showing that the lightest platelets were more activated in vivo. They further contained more P-selectin than peak platelets. ET platelets could be a mixture of cells produced by clonal and healthy megakaryocytes. As a consequence, the latter cells could be responsible for platelet density diversity. It is also tenable that malignant megakaryocytes produce platelets with a different density. Thus, similarities to healthy individuals with respect to platelet density distribution could explain why bleedings do not occur more frequently in ET.
In recent years, interest in platelet subpopulations has increased most notably with regard to the description of coat platelets [24] . These cells express high levels of procoagulant proteins after maximal stimulation with collagen and thrombin. Coat platelets constitute approximately 30% of the total platelet population [24] . For instance, Alzheimer's disease is characterized by an increased number of coat platelets and these cells are associated with disease progression [25] . Others have described a subpopulation of circulating activated platelets in acute coronary syndromes. It is impossible to stimulate these platelets further [26] . These examples indicate that it is possible that platelet subpopulations are important in human pathophysiology.
The Percoll gradients included a 'blocking solution' containing prostaglandin E 1 to avoid artifacts due to platelet activation during separation. The control experiment, i.e. ADP challenge, did not raise platelet-bound fibrinogen significantly ( fig. 1-4 ) . Thus, the inhibition solution blocks platelet activity effectively. High-density platelets demonstrate more surface-bound fibrinogen. As a consequence, they circulate in an activated state. These cells also contained less CD40L and P-selectin than neighboring less dense platelets. The findings suggest in vivo release reactions. The lightest platelets could be contaminated with extracellular P-selectin and CD40L from plasma located at the top of the gradient. This may explain why these platelets contain more CD40L and P-selectin than neighboring denser platelets. The location of CD40L in unstimulated platelets is not known. However, ␣ granule release is associated with CD40L translocation [20] . The densest platelets with signs of platelet in vivo activity contained less CD40L and P-selectin. This finding indicates [20] that CD40L liberation is closely related to ␣ granule degranulation.
Low-density platelets contained more P-selectin indicating enhanced ␣ granule content. Earlier work [21] shows that low-density populations have less dense bodies. Thus, low levels of dense granule and glycogen could explain why these cells have low densities despite enhanced ␣ granule content. A previous study from our laboratory concluded that platelets utilize intracellular fibrinogen when activated in surroundings depleted of Ca 2+ and fibrinogen [21] . The conclusion was premature. In contrast to our previous hypothesis, this study shows that platelet-bound fibrinogen reflects in vivo platelet activity with a high degree of certainty.
The current study demonstrates that ET patients and healthy volunteers display similar platelet density patterns. Some caveats exist, most notably the low sample size. However, each subject has been investigated extensively. The work makes it tenable to hypothesize that platelet density variations in ET at least partly explain why bleedings do not occur more frequently. The present study stimulates further research to evaluate the role of platelet subpopulations in human physiology and in disease state.
